Log in to save to my catalogue

Long-Term Outcomes of the ADRENAL Trial

Long-Term Outcomes of the ADRENAL Trial

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2031421302

Long-Term Outcomes of the ADRENAL Trial

About this item

Full title

Long-Term Outcomes of the ADRENAL Trial

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2018-05, Vol.378 (18), p.1744-1745

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In the ADRENAL trial, among adult patients with septic shock, hydrocortisone did not lead to lower mortality than placebo. Now, a prespecified secondary analysis shows that hydrocortisone did not affect mortality 6 months after randomization.

Alternative Titles

Full title

Long-Term Outcomes of the ADRENAL Trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2031421302

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2031421302

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMc1803563

How to access this item